74 related articles for article (PubMed ID: 18173758)
41. Transcriptional regulation of the human prostacyclin receptor gene is dependent on Sp1, PU.1 and Oct-1 in megakaryocytes and endothelial cells.
Turner EC; Kinsella BT
J Mol Biol; 2009 Feb; 386(3):579-97. PubMed ID: 19118563
[TBL] [Abstract][Full Text] [Related]
42. Estrogen receptor-alpha and -beta regulate the human corticotropin-releasing hormone gene through similar pathways.
Chen XN; Zhu H; Meng QY; Zhou JN
Brain Res; 2008 Aug; 1223():1-10. PubMed ID: 18597742
[TBL] [Abstract][Full Text] [Related]
43. GSTP1 promoter haplotypes affect DNA methylation levels and promoter activity in breast carcinomas.
Rønneberg JA; Tost J; Solvang HK; Alnaes GI; Johansen FE; Brendeford EM; Yakhini Z; Gut IG; Lønning PE; Børresen-Dale AL; Gabrielsen OS; Kristensen VN
Cancer Res; 2008 Jul; 68(14):5562-71. PubMed ID: 18632608
[TBL] [Abstract][Full Text] [Related]
44. Retinoic acid receptor gamma activates receptor tyrosine kinase Tie1 gene transcription through transcription factor GATA4 in F9 stem cells.
Su D; Gudas LJ
Exp Hematol; 2008 May; 36(5):624-41. PubMed ID: 18439490
[TBL] [Abstract][Full Text] [Related]
45. Autocrine BMP4 signalling regulates ID3 proto-oncogene expression in human ovarian cancer cells.
Shepherd TG; Thériault BL; Nachtigal MW
Gene; 2008 May; 414(1-2):95-105. PubMed ID: 18372118
[TBL] [Abstract][Full Text] [Related]
46. Functional characterization of the 5'-regulatory region of human factor IX gene.
Salier JP; Hirosawa S; Kurachi K
J Biol Chem; 1990 Apr; 265(12):7062-8. PubMed ID: 2324113
[TBL] [Abstract][Full Text] [Related]
47. [Characterization of human coagulation factor IX cDNA expressed in cultured cells and in transgenic mice].
Hu Y; Qiu X; Xue J; Liu Z
Yi Chuan Xue Bao; 1995; 22(3):161-6. PubMed ID: 8851867
[TBL] [Abstract][Full Text] [Related]
48. Functional analysis of the factor IX epidermal growth factor-like domain mutation Ile66Thr associated with mild hemophilia B.
Knobe KE; Persson KE; Sjörin E; Villoutreix BO; Ljung RC
Pathophysiol Haemost Thromb; 2006; 35(5):370-5. PubMed ID: 17230038
[TBL] [Abstract][Full Text] [Related]
49. Allelic heterogeneity of molecular events in human coagulation factor IX in Asian Indians. Mutation in brief #965. Online.
Mahajan A; Chavali S; Ghosh S; Kabra M; Chowdhury MR; ; Bharadwaj D
Hum Mutat; 2007 May; 28(5):526. PubMed ID: 17397055
[TBL] [Abstract][Full Text] [Related]
50. Genetic determinants of normal variation in coagulation factor (F) IX levels: genome-wide scan and examination of the FIX structural gene.
Khachidze M; Buil A; Viel KR; Porter S; Warren D; Machiah DK; Soria JM; Souto JC; Ameri A; Lathrop M; Blangero J; Fontcuberta J; Warren ST; Almasy L; Howard TE
J Thromb Haemost; 2006 Jul; 4(7):1537-45. PubMed ID: 16839351
[TBL] [Abstract][Full Text] [Related]
51. Further evidence for the importance of an androgen response element in the factor IX promoter.
Morgan GE; Rowley G; Green PM; Chisholm M; Giannelli F; Brownlee GG
Br J Haematol; 1997 Jul; 98(1):79-85. PubMed ID: 9233568
[TBL] [Abstract][Full Text] [Related]
52. Characterization of recombinant human factor IX expressed in transgenic mice and in derived trans-immortalized hepatic cell lines.
Jallat S; Perraud F; Dalemans W; Balland A; Dieterle A; Faure T; Meulien P; Pavirani A
EMBO J; 1990 Oct; 9(10):3295-301. PubMed ID: 2209546
[TBL] [Abstract][Full Text] [Related]
53. [Genetic aspects of high variability of lipoprotein(a) levels].
Zídková K; Zlatohlávek L; Ceska R
Cas Lek Cesk; 2007; 146(8):653-7. PubMed ID: 17874731
[TBL] [Abstract][Full Text] [Related]
54. Galectin 3-binding protein is a potential contaminant of recombinantly produced factor IX.
Blostein M; Cuerquis J; Galipeau J
Haemophilia; 2007 Nov; 13(6):701-6. PubMed ID: 17973845
[TBL] [Abstract][Full Text] [Related]
55. Purification, identification, and characterization of elastase on erythrocyte membrane as factor IX-activating enzyme.
Iwata H; Kaibara M; Dohmae N; Takio K; Himeno R; Kawakami S
Biochem Biophys Res Commun; 2004 Mar; 316(1):65-70. PubMed ID: 15003512
[TBL] [Abstract][Full Text] [Related]
56. Genetic mechanisms of age regulation of human blood coagulation factor IX.
Kurachi S; Deyashiki Y; Takeshita J; Kurachi K
Science; 1999 Jul; 285(5428):739-43. PubMed ID: 10426997
[TBL] [Abstract][Full Text] [Related]
57. Human populations show reduced DNA sequence variation at the factor IX locus.
Harris EE; Hey J
Curr Biol; 2001 May; 11(10):774-8. PubMed ID: 11378388
[TBL] [Abstract][Full Text] [Related]
58. Comparative sequence analysis of mammalian factor IX promoters.
Pang CP; Crossley M; Kent G; Brownlee GG
Nucleic Acids Res; 1990 Nov; 18(22):6731-2. PubMed ID: 2251157
[No Abstract] [Full Text] [Related]
59. Morphology of Drosophila S-2 cells in different culture conditions.
Søndergaard L
In Vitro Cell Dev Biol Anim; 1994 Jan; 30A(1):18-20. PubMed ID: 8193768
[No Abstract] [Full Text] [Related]
60. Identification and functional characterization of a polymorphic oestrogen response element in the human coagulation factor IX gene promoter.
Adams B; Western AK; Winship PR
Br J Haematol; 2008 Jan; 140(2):241-9. PubMed ID: 18173758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
